Nilay Thakar focuses on identifying and evaluating new life sciences technologies and provides operating assistance to early-stage portfolio companies. He has authored 7 peer-reviewed publications with greater than 150 citations in the areas of neuroscience, stem cell biology, intracellular signalling, and epigenetics. Previously, Dr. Thakar led the turnaround of an Australian biotech start-up Stem Cells Limited, served as a Think Tank Advisor at the Australian Academy of Sciences, and worked as an Analyst at Dendright Pty Ltd, a biotech start-up developing a Rheumatoid Arthritis therapeutic. Dr. Thakar also conceived an app to help blind Australians use public transport and was selected a Finalist for Queensland Government Open Data Award.
Dr. Thakar holds a B.S. in Biochemistry (High-Distinction honors), a Ph.D. in Cell Biology from the University of Queensland in Australia, and an M.B.A. from the University of Chicago Booth School of Business.